Olomi J, Msemwa J, Mponda B
Int J Surg Case Rep. 2024; 122:110142.
PMID: 39126934
PMC: 11367130.
DOI: 10.1016/j.ijscr.2024.110142.
Li Y, Zhang Z, Liu J, Wu Z, Sun X, Zhao Y
BMC Surg. 2022; 22(1):69.
PMID: 35219291
PMC: 8882289.
DOI: 10.1186/s12893-022-01521-2.
Bocle H, Lavigne J, Cellier N, Crouzet J, Kouyoumdjian P, Sotto A
BMC Musculoskelet Disord. 2021; 22(1):315.
PMID: 33784991
PMC: 8008605.
DOI: 10.1186/s12891-021-04191-y.
Tonnelier M, Bouras A, Joseph C, El Samad Y, Brunschweiler B, Schmit J
BMC Infect Dis. 2021; 21(1):174.
PMID: 33579208
PMC: 7881571.
DOI: 10.1186/s12879-021-05832-2.
Marsot A, Menard A, Dupouey J, Allanioux L, Blin O, Guilhaumou R
Br J Clin Pharmacol. 2020; 86(11):2319-2324.
PMID: 32330996
PMC: 7576626.
DOI: 10.1111/bcp.14319.
Efficacy of cotrimoxazole (Sulfamethoxazole-Trimethoprim) as a salvage therapy for the treatment of bone and joint infections (BJIs).
Deconinck L, Dinh A, Nich C, Tritz T, Matt M, Senard O
PLoS One. 2019; 14(10):e0224106.
PMID: 31622440
PMC: 6797119.
DOI: 10.1371/journal.pone.0224106.
Therapeutic outcome of spinal implant infections caused by Staphylococcus aureus: A retrospective observational study.
Cho O, Bae I, Moon S, Park S, Kwak Y, Kim B
Medicine (Baltimore). 2018; 97(40):e12629.
PMID: 30290637
PMC: 6200525.
DOI: 10.1097/MD.0000000000012629.
Species and antimicrobial susceptibility testing of coagulase-negative staphylococci in periprosthetic joint infections.
Lourtet-Hascoet J, Felice M, Bicart-See A, Bouige A, Giordano G, Bonnet E
Epidemiol Infect. 2018; 146(14):1771-1776.
PMID: 29880073
PMC: 9506689.
DOI: 10.1017/S0950268818001437.
Bacteriological aspects of chronic osteoarticular infections in adults: the influence of the osteosynthesis material.
Maleb A, Frikh M, Ben Lahlou Y, Chagar B, Lemnouer A, Elouennass M
BMC Res Notes. 2017; 10(1):635.
PMID: 29183358
PMC: 5704374.
DOI: 10.1186/s13104-017-2976-z.
Population pharmacokinetics of rifampicin in adult patients with osteoarticular infections: interaction with fusidic acid.
Marsot A, Menard A, Dupouey J, Muziotti C, Guilhaumou R, Blin O
Br J Clin Pharmacol. 2016; 83(5):1039-1047.
PMID: 27813241
PMC: 5401979.
DOI: 10.1111/bcp.13178.
Outcome of patients with streptococcal prosthetic joint infections with special reference to rifampicin combinations.
Fiaux E, Titecat M, Robineau O, Lora-Tamayo J, El Samad Y, Etienne M
BMC Infect Dis. 2016; 16(1):568.
PMID: 27737642
PMC: 5064929.
DOI: 10.1186/s12879-016-1889-0.
MALDI-TOF MS performance compared to direct examination, culture, and 16S rDNA PCR for the rapid diagnosis of bone and joint infections.
Lallemand E, Coiffier G, Arvieux C, Brillet E, Guggenbuhl P, Jolivet-Gougeon A
Eur J Clin Microbiol Infect Dis. 2016; 35(5):857-66.
PMID: 26942744
DOI: 10.1007/s10096-016-2608-x.
Influence of daily dosage and frequency of administration of rifampicin-levofloxacin therapy on tolerance and effectiveness in 154 patients treated for prosthetic joint infections.
Nguyen S, Robineau O, Titecat M, Blondiaux N, Valette M, Loiez C
Eur J Clin Microbiol Infect Dis. 2015; 34(8):1675-82.
PMID: 25987246
DOI: 10.1007/s10096-015-2404-z.
Antimicrobial-related severe adverse events during treatment of bone and joint infection due to methicillin-susceptible Staphylococcus aureus.
Valour F, Karsenty J, Bouaziz A, Ader F, Tod M, Lustig S
Antimicrob Agents Chemother. 2013; 58(2):746-55.
PMID: 24247130
PMC: 3910824.
DOI: 10.1128/AAC.02032-13.
Clinical spectrum and outcome of critically ill patients suffering from prosthetic joint infections.
Maaloum Y, Meybeck A, Olive D, Boussekey N, Delannoy P, Chiche A
Infection. 2012; 41(2):493-501.
PMID: 23097026
DOI: 10.1007/s15010-012-0357-z.
